Pancreatic Cancer Research

RetractionPLoS One2024

Retraction: Epithelial-Mesenchymal Transition Markers and HER3 Expression Are Predictors of Elisidepsin Treatment Response in Breast and Pancreatic Cancer Cell Lines.

Journal
PLoS One
Published
5 February 2024
Citations
0
Type
Retraction
License
cc by
Full text
Open access, reuse-licensed (cc by)
Retracted
Yes

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Its licensed text is not loaded here yet, so most questions will be declined.

Try